During the past decade, Allergy & Respiratory Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Allergy & Respiratory Center" #1 sponsor was "Allergy Therapeutics" with 2 trials, followed by "Teva Branded Pharmaceutical Products R&D, Inc." with 2 trials sponsored, "Dynavax Technologies Corporation" with 1 trials sponsored, "Genentech, Inc." with 1 trials sponsored and "Greer Laboratories" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Allergy & Respiratory Center" #1 collaborator was "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Allergy & Respiratory Center" are "Asthma" (4 trials), "Type I Hypersensitivity" (2 trials), "Allergic Rhinitis" (1 trials), "Persistent Allergic Asthma" (1 trials) and "Rhinitis, Allergic, Seasonal" (1 trials). Many other conditions were trialed in "Allergy & Respiratory Center" in a lesser frequency.

Most popular intervention types in "Allergy & Respiratory Center" are "Biological" (5 trials), "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Omalizumab" (2 trials), "Albuterol" (1 trials), "Amb a 1 immunostimulatory oligodeoxyribonucleotide conjugate" (1 trials) and "Grass MATA MPL" (1 trials). Other intervention names were less common.

The vast majority of trials in "Allergy & Respiratory Center" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Allergy & Respiratory Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Allergy & Respiratory Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Allergy & Respiratory Center, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".